Matinas BioPharma Holdings (MTNB) Preferred Dividend Payments (2016 - 2021)
Matinas BioPharma Holdings (MTNB) posted quarterly Preferred Dividend Payments of $201.0 for Q4 2021, down 99.91% year-over-year from $218050.0 in Q4 2020, and down 99.89% quarter-over-quarter from $184899.0 in Q2 2021.
Matinas BioPharma Holdings (MTNB) Preferred Dividend Payments (2016 - 2021) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has reported Preferred Dividend Payments for 6 consecutive years, with $201.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Preferred Dividend Payments fell 99.91% year-over-year to $201.0; the TTM figure through Dec 2021 stood at $396000.0 (down 50.09% YoY), while the FY2021 annual figure was $396000.0, down 50.09% from the prior year.
- Preferred Dividend Payments slipped to $201.0 in Q4 2021 per MTNB's latest filing, from $184899.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $227600.0 in Q3 2020 and bottomed at $201.0 in Q4 2021.
- Historically, Preferred Dividend Payments has averaged $151335.7 across 5 years, with a median of $149036.0 in 2017.
- Annual changes were most pronounced in 2020 — Preferred Dividend Payments soared 405.32% — and 2021, when it sank 99.91%.
- Matinas BioPharma Holdings' Preferred Dividend Payments stood at $146157.0 in 2017, then advanced by 0.43% to $146786.0 in 2018, then plunged by 69.32% to $45041.0 in 2019, then jumped by 384.11% to $218050.0 in 2020, then tumbled by 99.91% to $201.0 in 2021.
- Business Quant data shows MTNB's Preferred Dividend Payments at $201.0 in Q4 2021, $184899.0 in Q2 2021, and $210900.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Matinas BioPharma Holdings | 1.25 Mn | 437,566.66 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 201.00 |
| Jun 30, 2021 | 184,899.00 |
| Mar 31, 2021 | 210,900.00 |
| Dec 31, 2020 | 218,050.00 |
| Sep 30, 2020 | 227,600.00 |
| Jun 30, 2020 | 177,092.00 |
| Mar 31, 2020 | 170,700.00 |
| Sep 30, 2019 | 45,041.00 |
| Jun 30, 2019 | 146,786.00 |
| Mar 31, 2019 | 146,786.00 |
| Dec 31, 2018 | 146,786.00 |
| Sep 30, 2018 | 146,786.00 |
| Jun 30, 2018 | 146,786.00 |
| Mar 31, 2018 | 147,286.00 |
| Dec 31, 2017 | 146,157.00 |
| Sep 30, 2017 | 150,786.00 |
| Jun 30, 2017 | 152,400.00 |
| Mar 31, 2017 | 159,000.00 |
| Sep 30, 2016 | 4.39 Mn |